Linked Data API

Show Search Form

Search Results

1038495
star this property registered interest false more like this
star this property date less than 2019-01-09more like thismore than 2019-01-09
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care remove filter
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Drugs: Innovation more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, whether it is an objective of the new NHS Long Term Plan to ensure that the most innovative drugs will be accessible to patients more quickly than they currently are. more like this
star this property tabling member constituency Torfaen more like this
star this property tabling member printed
Nick Thomas-Symonds remove filter
star this property uin 206878 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-01-18more like thismore than 2019-01-18
star this property answer text <p>The NHS Long Term Plan, together with other recent initiatives including the Life Sciences Sector Deal and the 2019 Voluntary Scheme for Branded Medicines Pricing, describe the Government’s objectives for a health and care system that delivers world leading patient care and health outcomes.</p><p> </p><p>The Government wants patients to benefit from effective new drugs and the Voluntary Scheme for Branded Medicines Pricing and Access agreed between the Department and the branded pharmaceutical industry commits to align the speed of National Institute for Health and Care Excellence technology appraisals for non-cancer medicines to the faster timeline for cancer medicines.</p><p> </p><p>In addition, the Life Sciences Industrial Strategy set out a vision of being a world-leader in developing and bringing to market innovative medicines to improve life-chances of United Kingdom patients. It highlighted the importance of evolving and simplifying the access system for new medicines by implementing, and building on, the findings of the Accelerated Access Review.</p>
star this property answering member constituency Winchester more like this
star this property answering member printed Steve Brine more like this
star this property question first answered
less than 2019-01-18T12:18:43.347Zmore like thismore than 2019-01-18T12:18:43.347Z
unstar this property answering member
4067
star this property label Biography information for Steve Brine remove filter
star this property tabling member
4479
unstar this property label Biography information for Nick Thomas-Symonds more like this